No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
CN Stock MarketDetailed Quotes
002198 Guangdong Jiaying Pharmaceutical
- 6.82
- -0.36-5.01%
Trading Jul 11 14:24 CST
3.46BMarket Cap126.30P/E (TTM)
7.19High6.69Low317.44KlotVolume7.10Open7.18Pre Close218.44MTurnover6.26%Turnover Ratio100.29P/E (Static)507.51MShares8.1352wk High4.66P/B3.46BFloat Cap4.6252wk Low7.90Limit Up507.51MShs Float20.79Historical High6.46Limit Down6.96%Amplitude1.02Historical Low0.05Dividend TTM6.88Avg Price168.24KlotAsk0.73%Div YieldTTM100Lot Size142.08KlotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Guangdong Jiaying Pharmaceutical (002198.SZ) plans to distribute 0.5 yuan per 10 shares on June 21 for ex-rights and ex-dividends.
Jiaying Pharmaceutical (002198.SZ) announced that it plans to distribute an annual equity of 0.5 yuan (tax included) per 10 shares to all shareholders in 2023. The ex-rights and ex-dividend date is June 21, 2024.
Some May Be Optimistic About Guangdong Jiaying Pharmaceutical's (SZSE:002198) Earnings
The market for Guangdong Jiaying Pharmaceutical Co., Ltd's (SZSE:002198) shares didn't move much after it posted weak earnings recently. We did some digging, and we believe the earnings are stronger
Jiaying Pharmaceutical (002198.SZ) announced first-quarter results, net profit of 5.1822 million yuan, a decrease of 57.47%
Jiaying Pharmaceutical (002198.SZ) released its report for the first quarter of 2024, achieving 944 operating income during the reporting period...
Guangdong Jiaying Pharmaceutical (SZSE:002198) Delivers Shareholders Favorable 9.6% CAGR Over 3 Years, Surging 16% in the Last Week Alone
It hasn't been the best quarter for Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) shareholders, since the share price has fallen 11% in that time. But over three years, the returns would
Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) shares have had a horrible month, losing 26% after a relatively good period beforehand. Instead of being rewarded, shareholders who have alre
Do Guangdong Jiaying Pharmaceutical's (SZSE:002198) Earnings Warrant Your Attention?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Sometimes these stories can cloud the minds
Comments
The last year's loss could be a temporary blip on the journey to a brighter future for Guangdong Jiaying Pharmaceutical. The company's profitability in the last three years would have been expected to drive a higher share price.
Guangdong Jiaying Pharmaceutical (SZSE:002198) Delivers Shareholders Favorable 9.6% CAGR Over 3 Years, Surging 16% in the Last Week Alone 1
Despite a high P/E ratio, the company's recent earnings trajectory is less appealing compared to the market. Investors overlook limited growth, hoping for a business turnaround. However, disappointment may loom if the P/E aligns with recent growth rates. The company's three-year earnings trends aren't impacting its high P/E as expected.
Guangdong Jiaying Pharmaceutical's impressive EPS growth and substantial insider ownership indicate promising growth potential and improved business economics.
Guangdong Jiaying Pharmaceutical shows significant net income growth despite seeming unimpressive ROE, suggesting efficient management. Full reinvestment of profits further adds to the company's positive outlook despite lower-than-average industry ROE.
Read more
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg